Dr. Catherine L. Roach, MD
Dermatology (Dermatology Physician)
5 Stevens St Ste 300
Greenville, SC 29605
Who else practices at this address →
Greenville County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Medical University of South Carolina College of Medicine (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 616
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: Medical University of South Carolina College of Medicine
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
SC license 87891
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Carolina Dermatology PA (9 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 616
- Services billed
- 4,164
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 692 | 143 |
| Destruction of precancer skin growth, 1 growth | 240 | 184 |
| New patient office or other outpatient visit, 30-44 minutes | 211 | 211 |
| Established patient office or other outpatient visit, 20-29 minutes | 209 | 148 |
| Biopsy of related skin growth, first growth | 173 | 140 |
| Destruction of skin growth, 1-14 growths | 150 | 128 |
| Established patient office or other outpatient visit, 30-39 minutes | 98 | 66 |
| New patient office or other outpatient visit, 45-59 minutes | 83 | 83 |
| Biopsy of related skin growth, each additional growth | 66 | 43 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 24 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 49 payments worth $1,938 in total to this clinician.
| UCB, Inc. | $1,046 |
|---|---|
| AbbVie Inc. | $171 |
| Sun Pharmaceutical Industries Inc. | $114 |
| Janssen Biotech, Inc. | $84.83 |
| Organogenesis Inc. | $69.43 |
| Novartis Pharmaceuticals Corporation | $65.02 |
| Incyte Corporation | $48.28 |
| Galderma Laboratories, L.P. | $44.31 |
| Consulting Fee | $975 |
|---|---|
| Food and Beverage | $963 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Feb 4, 2025 | Consulting Fee Bimzelx · Immunology | $975 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.